Researchers paid by Medtronic hid side-effects of Infuse, scientists allege
This article was originally published in Clinica
Executive Summary
Medtronic is facing further criticism over its Infuse bone graft product, with a group of scientists alleging that the company has tried to hush up side-effects caused by the synthetic bone growth factor used in the product.